Atlas Trials

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Clinical trial NCT03990571 · COMPLETED

Trial details

NCT number
NCT03990571
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Adenoid Cystic CarcinomaProgressive DiseaseRecurrent Adenoid Cystic Carcinoma
Start date
2019-07-22
Primary completion
2023-03-20
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.